LONDON, Sept. 17, 2002 (PRIMEZONE) -- Interview available now on www.cantos.com with Stephen P A Fodor, Affymetrix (Nasdaq:AFFX) Chairman and Chief Executive Officer.
Stephen tackles issues around remaining the dominant supplier of gene expression analysis tools; the impact of the slowdown of R&D spending amongst Pharma and Biotech companies and the push to develop higher data point density per gene chip.
Interviews with Genzyme General, Sepracor and Vertex also available on Cantos today.
This interview is available in video, audio and transcript.
It's free to view. All you need to do is register at http://www.cantos.com.
Cantos.com is an online financial website where top management of companies address the critical issues facing their businesses.
If you would like to contact us, please email enquiries@cantos.com.